R R

What is Angioedema?

Angioedema is a condition characterized by sudden, severe swelling beneath the skin and mucous membranes. It is closely related to hives (urticaria), but the swelling occurs deeper in the tissue, generally affecting the lips, eyes, hands, feet, or genitals.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

What is Angioedema?

Angioedema is a condition characterized by sudden, severe swelling beneath the skin and mucous membranes. It is closely related to hives (urticaria), but the swelling occurs deeper in the tissue, generally affecting the lips, eyes, hands, feet, or genitals.

read more about angioedema ...

Copy this HTML:

Copy HTML Copied!

How is Angioedema Triggered and What is the Mechanism of Swelling?

Angioedema is triggered by either an allergic reaction to food, medication, or insect venom or a non-allergic reaction caused by drugs like ACE inhibitors. The swelling results from the sudden release of inflammatory mediators like histamine or bradykinin.

These chemicals cause fluid to leak rapidly from blood vessels into the surrounding tissue. This rapid fluid accumulation can cause significant discomfort and, critically, poses a threat if it affects the throat. The severity of the reaction depends on the specific chemical mediator released and the speed of the body's response to the trigger.

What Symptoms are Associated with Deep Tissue Swelling and Where Does it Occur?

Symptoms are associated with severe, localized puffiness and discomfort instead of the itching associated with surface hives. The swelling typically affects soft tissues like the eyelids, lips, tongue, and throat. It usually develops quickly over minutes to hours.

Swelling of the tongue or throat can lead to difficulty swallowing or breathing and constitutes a medical emergency. Because the swelling happens deep under the skin, applying pressure generally leaves no indentation, which helps differentiate it from general edema.

Diagnostic Procedures

Diagnosis is usually clinical. It is based on the rapid onset and appearance of the swelling. Blood tests may be performed to check for allergic markers (IgE) or deficiencies in certain proteins (C1 esterase inhibitor). These tests help to rule out hereditary forms of the condition.

How Does This Condition Impact Vision or Eye Health?

Angioedema impacts eye health by causing sudden, massive swelling of the eyelids. This swelling can cause temporary difficulty seeing or closing the eyes, but it rarely affects the eye itself. It can also cause severe swelling of the conjunctiva (chemosis). This is usually alarming but not generally painful.

How is Angioedema Treated?

Treatment is urgent if the airway is involved. Allergic angioedema is treated with epinephrine, antihistamines, and corticosteroids. Drug-induced swelling may require specialized non-histamine-based medications. Identifying and avoiding the trigger is needed for long-term prevention.

FAQs on Angioedema

Is angioedema always an allergic reaction?

No, angioedema can be hereditary or caused by certain medications like blood pressure drugs (ACE inhibitors). These causes are non-allergic.

Is throat swelling an emergency?

Yes, swelling of the throat or tongue is a medical emergency because it can quickly block the airway.

Does angioedema leave marks?

No, the swelling generally subsides completely within a day or two without leaving any residual marks.

When to See Your Doctor

If you experience recurring swelling without hives, you may have "Hereditary Angioedema." This requires specialized blood tests for C1-esterase inhibitor levels. If angioedema affects your eyelids, avoid rubbing them, as the tissue is very delicate and prone to secondary bruising.

References

AAO. Eye Swelling and Angioedema (aao.org). 2024.

Mayo Clinic. Angioedema Symptoms (mayoclinic.org). 2024.

StatPearls. Hereditary Angioedema (ncbi.nlm.nih.gov). 2024.

MedlinePlus. Angioedema (medlineplus.gov). 2025.